Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Surgery, By Region, And Segment Forecasts, 2018 - 2024 - Product Image

Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Surgery, By Region, And Segment Forecasts, 2018 - 2024

  • ID: 4538871
  • Report
  • 110 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • AxoGen, Inc.
  • Boston Scientific, Inc.
  • Cyberonics, Inc.
  • Medtronic plc.
  • Polyganics B.V.
  • St. Jude Medical, Inc.
  • MORE
The global nerve repair and regeneration market is expected to reach USD 15.7 billion by 2024, according to a new report by The report Inc. The demand for neurological disorder devices and therapies is expected to upsurge over the forecast period owing to rising awareness, increasing incidence rate, government funding & reimbursement policies, and uninterrupted technological advances by the key players of the industry (nerve control and regeneration technique is a rapidly growing division of neural tissue engineering). It has been estimated that more than 0.8 million people were affected due to nervous system injuries per year.

In January 2016, The EU Horizon 2020 program funded a research project ‘Autostem’ launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI) costing about USD 6.73 million. This project was expected to develop a robotic stem cell production factory, having an edge over the old traditional techniques. Also, this technique will treat a range of therapies pertaining to cancer, diabetes, arthritis and other diseases.

Investment by market players in research & development and commercialization in emerging countries are the major factors to drive the market growth in coming years. For instance, in October 2015, Helius Medical signed an agreement with A&B Company Limited for the development and commercialization of Helius’ Portable Neuromodulation Stimulator in Singapore, Taiwan, Hong Kong, Macao, and China. Under this agreement, A&B is expected to acquire certain Asian patents ownership, product support material, and patent applications for the PoNS device.

Further key findings from the study suggest:
  • Neurostimulation and neuromodulation devices dominated the product segment of the market in 2015 due to the rising awareness about the devices, coupled with the increasing central nervous system disorders in the population.
  • Biomaterials segment is anticipated to grow at the fastest rate during the forecast period. This can be attributed to technological advancement, development of biodegradable polymers which are expected to enhance spinal stabilization, healing of fractures, & reduce hospitalization, and rising adoption.
  • North America dominated the market in 2015 owing to the technological advancements in the region and the introduction of new devices by the manufacturers. In 2015, U.S proved to be the most potential market. Increasing injuries to the central nervous system (CNS), including injuries to the spinal cord and the brain, increased cases, initiatives and funding from governments and various other agencies were some of the major reasons of growth.
  • According to the report published by the Florida university, more than 2 million people were suffering with traumatic injuries of the brain in the US annually and 5,00,000 people suffered due to the spinal cord injuries. The major causes of CNS injuries result from poorly understood biochemical pathological events.
  • Also, In March 2016, Baxter completed the CE marking, the indication for marketing of ‘HEMOPATCH’ the ready-to-use surgical patch in the European market. This patch was approved for use during traumatic injuries of the brain, CNS or other body parts that result in shrinkage of dura mater also, as a hemostatic device to prevent loss of blood or any other body fluid.
  • Asia Pacific is expected to be the fastest growing region during the forecast period. An aging population, technological advancement and presence of unmet medical needs are some of the reasons for the growth of the market.
  • In February 2016, Indian scientists working for Revita Life Sciences were approved to conduct clinical trials in 20 clinically dead patients to bring specific parts of their central nervous system back to life. Combination of therapies including cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells and other techniques that were successful in bringing patients out of coma were to be used. Existing medical devices were combined with regenerative biological medicines with an objective to achieve such a complex initiative.
  • Manufacturers are conducting collaborative exercises by use of innovative devices and therapies to improve the efficiency of treatment and provide better results.
  • Some key players in this industry include Boston Scientific, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic plc., Baxter International, Inc., AxoGen, Inc., Polyganics B.V., Integra Lifesciences Corporation, and Cyberonics, Inc.


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AxoGen, Inc.
  • Boston Scientific, Inc.
  • Cyberonics, Inc.
  • Medtronic plc.
  • Polyganics B.V.
  • St. Jude Medical, Inc.
  • MORE
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources

Chapter 2. Executive Summary
2.1. Nerve Repair and Regeneration - Industry snapshot and key buying criteria, 2016 - 2024

Chapter 3. Nerve Repair and Regeneration Industry Outlook
3.1. Nerve repair and regeneration market segmentation
3.2. Nerve repair and regeneration market size and growth prospects, 2016 - 2024
3.3. Nerve repair and regeneration: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increased government funding and recommendations
3.3.1.2. Technological advances and introduction of new therapies by global players of this market.
3.3.2. Market restraint analysis
3.3.2.1. Legal issues
3.3.2.2. Higher cost of treatment
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Nerve repair and regeneration: competitive landscape
3.6.1. Competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
3.7. Nerve repair and regeneration PESTEL analysis, 2015
3.7.1 Nerve repair and regeneration technology: Future aspects

Chapter 4. Nerve Repair and Regeneration Product Outlook
4.1. Nerve repair and regeneration market share by product, 2016 & 2024
4.2. Biomaterials
4.2.1. Biomaterials market estimates, 2013 - 2015 (USD Million)
4.2.2. Biomaterials market forecasts, 2016 - 2024 (USD Million)
4.3. Neurostimulation and Neuromodulation Devices
4.3.1. Neurostimulation and neuromodulation devices market estimates, 2013 - 2015 (USD Million)
4.3.2. Neurostimulation and neuromodulation devices market forecasts, 2016 - 2024 (USD Million)
4.3.3. Spinal cord stimulation devices market estimates, 2013 - 2015 (USD Million)
4.3.4. Spinal cord stimulation devices market forecasts, 2016 - 2024 (USD Million)
4.3.5. Deep brain stimulation devices market estimates, 2013 - 2015 (USD Million)
4.3.6. Deep brain stimulation devices market forecasts, 2016 - 2024 (USD Million)
4.3.7. Sacral nerve stimulation devices market estimates, 2013 - 2015 (USD Million)
4.3.8. Sacral nerve stimulation devices market forecasts, 2016 - 2024 (USD Million)
4.3.9. Vagus nerve stimulation devices market estimates, 2013 - 2015 (USD Million)
4.3.10. Vagus nerve stimulation devices market forecasts, 2016 - 2024 (USD Million)
4.3.11. Gastric electric stimulation devices market estimates, 2013 - 2015 (USD Million)
4.3.12. Gastric electric stimulation devices market forecasts, 2016 - 2024 (USD Million)

Chapter 5. Nerve Repair and Regeneration Surgery Outlook
5.1. Nerve repair and regeneration market share by application, 2016 & 2024
5.2. Direct nerve repair/neurorrhaphy
5.2.1. Direct nerve repair/neurorrhaphy market estimates, 2013 - 2015 (USD Million)
5.2.2. Direct nerve repair/neurorrhaphy market forecasts, 2016 - 2024 (USD Million)
5.3. Nerve grafting
5.3.1. Nerve grafting market estimates, 2013 - 2015 (USD Million)
5.3.2. Nerve grafting market forecasts, 2016 - 2024 (USD Million)
5.4. Stem cell therapy
5.4.1. Stem cell therapy market estimates, 2013 - 2015 (USD Million)
5.4.2. Stem cell therapy forecasts, 2016 - 2024 (USD Million)
5.5. Neurostimulation and neuromodulation surgeries
5.5.1. Neurostimulation and neuromodulation surgeries market estimates, 2013 - 2015 (USD Million)
5.5.2. Neurostimulation and neuromodulation surgeries market forecasts, 2016 - 2024 (USD Million)

Chapter 6. Nerve Repair and Regeneration Regional Outlook
6.1. North America
6.1.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
6.1.2. Nerve repair and regeneration market forecasts, by product, 2016 - 2024 (USD Million)
6.1.3. Nerve repair and regeneration market estimates, by surgery, 2013 - 2015 (USD Million)
6.1.4. Nerve repair and regeneration market forecast, by surgery, 2016 - 2024 (USD Million)
6.1.4.1. U.S.
6.1.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.1.4.1.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.1.4.2. Canada
6.1.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.1.4.2.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.2. Europe
6.2.1. Nerve repair and regeneration market estimates, by product 2013 - 2015 (USD Million)
6.2.2. Nerve repair and regeneration market forecast, by product, 2016 - 2024 (USD Million)
6.2.3. Nerve repair and regeneration market estimates by surgery, 2013 - 2015 (USD Million)
6.2.4. Nerve repair and regeneration market forecast by surgery, 2016 - 2024 (USD Million)
6.2.4.1. UK
6.2.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.2.4.1.2. Nerve repair and regeneration marketforecasts, 2016 - 2024 (USD Million)
6.2.4.2. Germany,
6.2.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.2.4.2.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.2.4.3. France
6.2.4.3.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.2.4.3.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.3. Asia Pacific
6.3.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
6.3.2. Nerve repair and regeneration market forecasts, by product, 2016 - 2024 (USD Million)
6.3.3. Nerve repair and regeneration market estimates, by application, 2013 - 2016 (USD Million)
6.3.4. Nerve repair and regeneration market forecasts, by application, 2016 - 2024 (USD Million)
6.3.4.1. India
6.3.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.3.4.1.2. Nerve repair and regeneration marketforecasts, 2016 - 2024 (USD Million)
6.3.4.2. China
6.3.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.3.4.2.2. Nerve repair and regeneration marketforecasts, 2016 - 2024 (USD Million)
6.3.4.3. Japan
6.3.4.3.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.3.4.3.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.4. Latin America
6.4.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
6.4.2. Nerve repair and regeneration forecasts, by product, 2016 - 2024 (USD Million)
6.4.3. Nerve repair and regeneration market estimates, by surgery, 2013 - 2016 (USD Million)
6.4.4. Nerve repair and regeneration forecasts, by surgery, 2016 - 2024 (USD Million)
6.4.4.1. Brazil
6.4.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.4.4.1.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.4.4.2. Mexico
6.4.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.4.4.2.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
6.5. MEA
6.5.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
6.5.2. Nerve repair and regeneration forecasts, by product, 2016 - 2024 (USD Million)
6.5.3. Nerve repair and regeneration market estimates, by surgery, 2013 - 2016 (USD Million)
6.5.4. Nerve repair and regeneration forecasts, by surgery, 2016 - 2024 (USD Million)
6.5.4.1. South Africa
6.5.4.1.1. South Africa nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
6.5.4.1.2. South Africa nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)

Chapter 7. Competitive Landscape
7.1. AxoGen, Inc.
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Baxter International, Inc.
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Boston Scientific, Inc.
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. St. Jude Medical, Inc.
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Cyberonics, Inc.
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Integra Lifesciences Corporation
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Medtronic plc.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Stryker Corporation
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Polyganics B.V.
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives

FList of Tables

Table 1 Nerve repair and regeneration market - Industry snapshot & key buying criteria, 2013 - 2024
Table 2 Global nerve repair and regeneration market, by product, 2013 - 2024 (USD Million)
Table 3 Global nerve repair and regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 4 Global nerve repair and regeneration market, by region, 2013 - 2024 (USD Million)
Table 5 Nerve repair and regeneration - Key market driver analysis
Table 6 Nerve repair and regeneration - Key market restraint analysis
Table 7 North America nerve repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 8 U.S. nerve repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 9 U.S.nerve repair and regeneration, by surgery, 2013 - 2024 (USD Million)
Table 10 Canada nerve repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 11 Canada Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 12 Europe Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 13 Europe Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 14 UK Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 15 UK Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 16 Germany Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 17 Germany Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million
Table 18 Asia Pacific Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 19 Asia Pacific Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 20 Japan Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 21 Japan Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 22 China Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 23 China Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 24 Latin America Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 25 Latin America Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 26 Brazil Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 27 Brazil Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 28 Mexico Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 29 Mexico Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 30 MEA Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 31 MEA Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
Table 32 South Africa Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
Table 33 South Africa Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Nerve repair and regeneration market segmentation
FIG. 2 Global nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 3 Nerve Repair and Regeneration market dynamics
FIG. 4 Key opportunities prioritized
FIG. 5 Nerve repair and regeneration market Porter’s analysis
FIG. 6 Nerve repair and regeneration market PESTEL analysis
FIG. 7 Nerve repair and regeneration competitive landscape, 2014
FIG. 8 Nerve repair and regeneration revenue share, by devices, 2013 - 2024
FIG. 9 Biomaterials market, 2013 - 2024 (USD Million)
FIG. 10 Neurostimulation and neuromodulation devices market, 2013 - 2024 (USD Million)
FIG. 11 Spinal Cord Stimulation Devices market, 2013 - 2024 (USD Million)
FIG. 12 Deep Brain Stimulation Devices market, 2013 - 2024 (USD Million)
FIG. 13 Sacral Nerve Stimulation Devices market, 2013 - 2024 (USD Million)
FIG. 14 Vagus Nerve Stimulation Devices market, 2013 - 2024 (USD Million)
FIG. 15 Gastric Electric Stimulation Devices market, 2013 - 2024 (USD Million)
FIG. 16 Nerve repair and regeneration revenue, share by surgery, 2013 - 2024
FIG. 17 Direct nerve repair/neurorrhaphy market, 2013 - 2024 (USD Million)
FIG. 18 Nerve grafting market, 2013 - 2024 (USD Million)
FIG. 19 Stem cell therapy market, 2013 - 2024 (USD Million)
FIG. 20 Neurostimulation and neuromodulation market, 2013 - 2024 (USD Million)
FIG. 21 Nerve repair and regeneration revenue share by region, 2013 & 2024
FIG. 22 North America nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 23 US nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 24 Canada nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 25 Europe nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 26 UK nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 27 Germany nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 28 France nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 29 Asia Pacific nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 30 Japan nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 31 China nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 32 India nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 33 Latin America nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 34 Brazil nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 35 Mexico nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 36 MEA nerve repair and regeneration market, 2013 - 2024 (USD Million)
FIG. 37 South Africa nerve repair and regeneration market, 2013 - 2024 (USD Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AxoGen, Inc.
  • Baxter International, Inc.
  • Boston Scientific, Inc.
  • St. Jude Medical, Inc.
  • Cyberonics, Inc.
  • Integra Lifesciences Corporation
  • Medtronic plc.
  • Stryker Corporation
  • Polyganics B.V.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll